Browse Category

NYSE:HIMS News 29 September 2025 - 17 October 2025

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Menopause Launch Sparks Surge in HIMS Stock Hims & Hers’ expansion into menopause care was greeted with enthusiasm in the market. On October 15, the San Francisco–based telehealth provider announced it is

17 October 2025

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

Hims & Hers Stock Soars on New Menopause Care Expansion – What Comes Next?

Hims & Hers’ women’s health platform (Hers) now offers specialized menopause and perimenopause care investors.hims.com. The new service is aimed at improving access to hormone therapies (estradiol, progesterone, etc.) for symptoms like

15 October 2025

Business News · Health Tech · Investment Trends · Menopause · NYSE:HIMS · Stock Market

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

“It’s never been more clear that we are delivering exactly what millions of people have been waiting for,” said HIMS CEO Andrew Dudum after Q2 results investors.hims.com. With analysts ranging from “Sell”

29 September 2025

FDA Regulation · Healthcare Stocks · Investment News · Market Trends · NYSE:HIMS · Stock Market · Weight Loss

Go toTop